1.
2.
Nat Biotechnol
; 34(3): 276-83, 2016 Mar.
Article
in English
| MEDLINE
| ID: mdl-26963550
3.
Sci Transl Med
; 2(13): 13cm1, 2010 Jan 06.
Article
in English
| MEDLINE
| ID: mdl-20371460
ABSTRACT
The research and development of innovative new therapies are expensive and risky processes, and companies require substantial resources if they are to translate basic science into modern biomedical products. When resources are limited, as in the current economic climate, biotechnology start-up companies are often among the first casualties in the fight for assets. Policy-makers can play an important role in bolstering these important innovators.
Subject(s)
Biotechnology/methods , Biomedical Research/economics , Biotechnology/economics , Biotechnology/trends , Drug Industry/economics , Humans , Public Policy , Research/economics , Research Support as Topic/economics , United States
4.
PDA J Pharm Sci Technol
; 64(1): 1-2, 2010.
Article
in English
| MEDLINE
| ID: mdl-21501997
5.
N J Med
; 100(11): 14-20, 2003 Nov.
Article
in English
| MEDLINE
| ID: mdl-14679599